CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes

International Immunology

Volumn 8, Issue 12, 1996, Pages 1927-1936

  Amsen, Derk ^a   Kruisbeek, Ada M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Central tolerance; Co stimulation; Negative selection

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CELLS, CULTURED; CLONAL DELETION; CROSS-LINKING REAGENTS; DRUG SYNERGISM; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030472261     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.12.1927     Document Type: Article

References (79)

1. Bevan, M. J. 1977. In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic T cells. Nature 269:417.
2. Zinkernagel, R. M., Callahan, G. N., Althage, A., Cooper, S., Klein, P. A. and Klein, J. 1978. On the thymus in the differentiation of 'H-2 self-recognition' by T cells: evidence for dual recognition? J. Exp. Med. 147:882.
3. + cytotoxic T cells requires interactions with class I MHC determinants. Nature 333:180.
4. Marusic-Galesic, S., Longo, D. L. and Kruisbeek, A. M. 1989. Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selection. J. Exp. Med. 169:1619.
5. Kisielow, P., Teh, H. S., Blüthmann, H. and Von Boehmer, H. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730.
6. Berg, L. J., Pullen, A. M., Fazekas de St Groth, B., Mathis, D., Benoist, C. and Davis, M. M. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58: 1035.
7. Kappler, J. W., Roehm, N. and Marrack, P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
8. + thymocytes. Nature 333:742.
9. lo thymocytes in vivo. Science 250:1720.
10. Nikolic-Zugic, J. and Bevan, M. J. 1990. Role of self-peptides in positively selecting the T-cell repertoire. Nature 344:65.
11. Jacobs, H., Von Boehmer, H., Melief, C. J. M. and Berns, A. 1990. Mutations in the major histocompatibility complex class I antigen-presenting groove affect both negative and positive selection of T cells. Eur. J. Immunol. 20:2333.
12. + T cells in the thymus. Cell 73:1041.
13. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
14. Sebzda, E., Wallace, V. A., Mayer, J., Yeung, R. S. M., Mak, T. W. and Ohashi, P. S. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615.
15. Sprent, J., Kosaka, H., Gao, E.-K., Surh, C. D. and Webb, S. R. 1993. Intrathymic and extrathymic tolerance in bone marrow chimeras. Immunol. Rev. 11:151.
16. Lo, D. and Sprent, J. 1986. Identity of cells that imprint H-2 restricted T-cell specificity in the thymus. Nature 329:672.
17. Benoist, C. and Mathis, D. 1989. Positive selection of the T cell repertoire: where and when does it occur? Cell 58:1027.
18. + T cells mediated by MHC class II-bearing stromal cell in the thymic cortex. Nature 341:649.
19. Carlow, D. A., Van Oers, N. S. C., Teh, S.-J. and Teh, H.-S. 1992. Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions. J. Immunol. 148:1595.
20. + thymocytes. J. Immunol. 151:1868.
21. + thymocytes by T cell receptor-induced apoptosis requires a co-stimulatory signal that can be provided by CD28. J. Exp. Med. 179:709.
22. Iwabuchi, K., Nakayma, I.-I., McCoy, R. L., Wang, F., Nishimura, T., Habu, S., Murphy, K. M. and Loh, D. Y. 1992. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes. Proc. Natl Acad. Sci. USA 89:9000.
23. Matzinger, P. and Guerder, S. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74.
24. Gross, J. A., Callas, E. and Allison, J. P. 1992. Identification and distribution of the co-stimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
25. Gravestein, L. A., Nieland, J. D., Kruisbeek, A. M. and Borst, J. 1995. Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int. Immunol. 7:551.
26. + thymocytes. J. Immunol. 149:3217.
27. Jones, L. A., Izon, D. J., Nieland, J. D., Linsley, P. S. and Kruisbeek, A. M. 1993. CD28-B7 interactions are not required for intrathymic clonal deletion. Int. Immunol. 5:503.
28. Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B. and Mak, T. W. 1993. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261:609.
29. Lucas, P. J., Negishi, I., Nakayama K., Fields, L. E. and Loh, D. Y. 1995. Naive CD28-deficient mice can initiate but not sustain an in vitro antigen specific immune response. J. Immunol. 154:5757.
30. Walunas, T. L., Sperling, A. I., Khattri, R., Thompson, C. B. and Bluestone, J. A. 1995. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156:1006.
31. Liu, Y., Jones, B., Aruffo, A., Sullivan, K. M., Linsley, P. S. and Janeway, C. A., Jr. 1992. Heat-stable antigen is a co-stimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:437.
32. Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., VandenBos, T., Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K., Falk, B., Cosman, D., Baker, E., Sutherland, G. R., Grabstein, K. H., Farrah, T., Giri, J. G. and Peckmann, M. P. 1993, Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:446.
33. + lymphocytes. J. Immunol. 152:1523.
34. Fanslow, W. C., Clifford, K. N., Seaman, M., Alderson, M. R., Spriggs, M. K., Armitage, R. J. and Ramsdell, F. 1994. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152:4262.
35. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D. H. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
36. Pollok, K. E., Kim, Y.-J., Zhou, Z., Hurtado, J., Kim, K. K., Pickard, R. T. and Kwon, B. S. 1993. Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150:664.
37. Smith, C. A., Gruss, H.-J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Grabstein, K. H., Gliniak, B., McAlister, I. B., Fanslow, W., Alderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W. S., Goodwin, R. G. and Armitage, R. J. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
38. Dialynas, D. P., Qyan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M. and Fitch, F. W. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
39. Oi, V., Jones, P., Gooding, J. and Herzenberg, L. 1978. Properties of monoclonal antibodies to mouse lg allotypes. H-2 and la antigens. Curr. Top. Microbiol. Immunol. 81:115.
40. Ozato, K., Mayer, N. and Sachs, D. H. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and la antigens. J. Immunol. 124:533.
41. Nabavi, N., Freeman, G. J., Gault, A., Godfrey, D., Nadler, L. M. and Glimcher, L. H. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
42. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradhsaw, J., Linsley, P. and Hodes, R. J. 1993. Identification of an alternative CTLA-4 ligand co-stimulatory for T cell activation. Science 262:905.
43. Goodman, T. and Lefrancois, L. 1989. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J. Exp. Med. 170:1569.
44. Ledbetter, J. A. and Herzenberg, L. A. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
45. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. and Bluestone, J. A. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl Acad. Sci. USA 84:1374.
46. Sarmiento, M., Glasebrook, A. L. and Fitch, F. W. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
47. Pullen, A. M., Marrack, P. and Kappler, J. W. 1988. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 335:796.
48. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
49. Germain, R. N. and Quill, H. 1986. Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells. Nature 320:72.
50. Miller, J. and Germain, R. N. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478.
51. Stockinger, B., Pessara, U., Lin, R. H., Habicht, J., Grez, M. and Koch, N. 1989. A role of la-associated invariant chains in antigen processing and presentation. Cell 56:683.
52. Van Pel, A., Vessière, F. and Boon, T. 1983. Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J. Exp. Med. 157:1992.
53. Jenkins, M. K. and Schwartz, R. H. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
54. Lyons, A. B., Samuel, K., Sanderson, A. and Maddy, A. H. 1992. Simultaneous analysis of immunophenotype and apoptosis of murine thymocytes by single laser flow cytometry. Cytometry 13:809.
55. Nicoletti, I., Migliorati, G., Paglicacci, M. C., Grignani, F. and Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
56. + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150.
57. Vasquez, N. J., Kaye, J. and Hedrick, S. M. 1992. In vivo and in vitro clonal deletion of double-positive thymocytes. J. Exp. Med. 175:1307.
58. Jenkins, M. K., Ashwell, J. D. and Schwartz, R. H. 1988. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140:3324.
59. Loss, G. E., Elias, C. G., Fields, P. E., Ribaudo, R. K., McKisic, M. and Sant, A. J. 1993. Major histocompatibility complex class II restricted presentation of internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J. Exp. Med. 178:73.
60. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
61. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C. and Nadler, L. M. 1991. B-cell surface antigen B7 provides a co-stimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl Acad. Sci. USA 88:6575.
62. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., Gray, G. S., Nadler, L. M. and Sharpe, A. H. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
63. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr, Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
64. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. J. 1994. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J. Exp. Med. 180:631.
65. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
66. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S. J, 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879.
67. Pircher, H., Rohrer, U. H., Moskophidis, D., Zinkernagel, R. M. and Hengartner, H. 1991. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351:482.
68. + thymocytes by T-cell receptor peptide antagonists. Proc. Natl Acad. Sci. USA 91:4057.
69. Mazda, O., Watanabe, Y., Gyotoku, J.-I. and Katsura, Y. 1991. Requirement of dendritic cells and B cells in the clonal deletion of Mis-reactive T cells in the thymus. J. Exp. Med. 173:539.
70. Nelson, A. J., Hosier, S., Brady, W., Linsley, P. S. and Farr, A. G. 1993. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J. Immunol. 151:2453.
71. + thymocytes. J. Immunol. 152:3254.
72. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA4. Science 270:985.
73. Tivol, E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone, J. A. and Sharpe, A. H. 1995. Loss of CTLA4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA4. Immunity 3:541.
74. + T cells by transgenic I-E restricted to thymic medullary epithelium. J. Immunol. 151:3954.
75. Foy, T. M., Page, D. M., Waldschmidt, T. J., Schoneveld, A., Laman, J. D., Masters, S. R., Tygrett, L., Ledbetter, J. A., Aruffo, A., Claassen, E., Xu, J. C., Flavell, R. A., Oehen, S., Hedrick, S. M. and Noelle R. J. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377.
76. Griggs, N. D., Agersborg, S. S., Noelle, R. J., Ledbetter, J. A., Linsley P. S. and Tung, K. S. K. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:801.
77. Amakawa, R., Hakem, A., Kundig, T. M., Matsyama, T., Simard, J. J. L., Timms, E., Wakeham, A., Mittruecker H.-W., Griesser, H., Takimoto, H., Schmits, R., Shahinian A., Ohashi, P. S., Penninger, J. M. and Mak, T. W. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
78. Amsen, D. and Kruisbeek, A. M. 1996. Mechanisms underlying T-cell tolerance. Curr. Opin. Immunol. 8:233.
79. Kishimoto, H., Cai, Z., Brunmark, A., Jackson, M. R., Peterson, P. A. and Sprent, J. 1996. Differing roles for B7 and intercellular adhesion molecule-1 in negative selection of thymocytes. J. Exp. Med. 184:531.